Literature DB >> 11175327

HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations.

T Matsuzaki1, M Nakagawa, M Nagai, Y Nobuhara, K Usuku, I Higuchi, K Takahashi, T Moritoyo, K Arimura, S Izumo, S Akiba, M Osame.   

Abstract

To clarify the existence of HAM/TSP presenting amyotrophic lateral sclerosis (ALS)-like manifestations, we assayed HTLV-I proviral load in peripheral blood mononuclear cells (PBMC) in 15 patients with anti-HTLV-I antibody in serum and ALS-like manifestations (upper motor neuron involvement in at least one region and lower motor neuron involvement in at least two limbs) by quantitative PCR, and compared the proviral load with that of 233 HAM/TSP patients and of 213 HTLV-I carriers. Five of 15 patients with ALS-like manifestations had proviral loads as high as those in the 233 patients with HAM/TSP. Anti-HTLV-I antibody in cerebrospinal fluid (CSF) was present in all of five patients. The proviral load in the remaining 10 patients was similar to that in HTLV-I carriers. Four of five patients with a high proviral load met the diagnostic criterion of HAM/TSP except for lower motor neuron involvement. These four patients showed high neopterin levels in CSF. On the basis of HTLV-I proviral load in PBMC and the clinical symptoms, our tentative conclusion is that these four patients are HAM/TSP presenting ALS-like manifestations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11175327     DOI: 10.3109/13550280009091955

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  13 in total

Review 1.  Neuroimmunity of HTLV-I Infection.

Authors:  Eiji Matsuura; Yoshihisa Yamano; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-02       Impact factor: 4.147

2.  Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis.

Authors:  Renée Douville; Jiankai Liu; Jeffrey Rothstein; Avindra Nath
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

Review 3.  Endogenous retrovirus-K and nervous system diseases.

Authors:  Mamneet Manghera; Jennifer Ferguson; Renée Douville
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

Review 4.  Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis.

Authors:  Wenxue Li; Darshan Pandya; Nicholas Pasternack; Marta Garcia-Montojo; Lisa Henderson; Christine A Kozak; Avindra Nath
Journal:  Neurotherapeutics       Date:  2022-04-12       Impact factor: 6.088

Review 5.  Molecular methods for diagnosis of viral encephalitis.

Authors:  Roberta L Debiasi; Kenneth L Tyler
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 6.  Amyotrophic lateral sclerosis with laboratory abnormalities of uncertain significance: A brief review.

Authors:  Majid Ghasemi; Farzad Fatehi; Bahador Asadi; Fariborz Khorvash
Journal:  Iran J Neurol       Date:  2012

7.  Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis.

Authors:  Jeremy A Garson; Louise Usher; Ammar Al-Chalabi; Jim Huggett; Edmund F Day; Adele L McCormick
Journal:  Acta Neuropathol Commun       Date:  2019-03-18       Impact factor: 7.801

Review 8.  Viruses and neurodegeneration.

Authors:  Li Zhou; Monica Miranda-Saksena; Nitin K Saksena
Journal:  Virol J       Date:  2013-05-31       Impact factor: 4.099

9.  Human Endogenous Retrovirus-K and TDP-43 Expression Bridges ALS and HIV Neuropathology.

Authors:  Renée N Douville; Avindra Nath
Journal:  Front Microbiol       Date:  2017-10-11       Impact factor: 5.640

Review 10.  Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Yoshimi Enose-Akahata; Steven Jacobson
Journal:  Retrovirology       Date:  2019-11-29       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.